Definitive Contract 75D30118C02926

The Washington University Office of Sponsored Research Services Division was awarded a definitive contract valued at approximately $499,305 by the Centers for Disease Control and Prevention (CDC) to conduct a toxicology study on negative health effects. The contract was awarded under the CDC's Pittsburgh office and will be performed by the prime contractor in University City, Missouri over a two year period from September 2017 through September 2019. No additional details were provided on...

The Centers for Disease Control and Prevention (CDC) awarded a $618,826.91 firm fixed price purchase order to The Washington University Office of Sponsored Research Services Division as the prime contractor. The contract is for one year of performance from September 30, 2023 through September 29, 2024 to support the CDC's research programs. As the prime, Washington University will leverage its expertise conducting federally-funded public health research. No subcontractors or additional context...

The Washington University Office of Sponsored Research Services Division has been awarded a definitive contract valued at $748,687 by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The contract is associated with CDC's Fiscal Year 2021 Broad Agency Announcement Topic 4.4 and will support the agency's public health programs. As a firm fixed price contract, Washington University will provide specified products or services to the CDC over a thirty-month period ending...

This $498,427 firm fixed-price federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to The Washington University, a private research university based in St. Louis, Missouri. The contract is for an "Intestinal Metabolic Factors Study" and does not have a set-aside designation. The Washington University has extensive experience as a prime contractor on federal research and development projects for various government agencies, including the Department of...

This is a $490,499 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Washington University, a private research university in St. Louis, Missouri. The contract is for an "Early Life Antibiotic Therapy Study" and does not have a set-aside designation. The Washington University has extensive experience as a prime contractor and subcontractor on federal research and development contracts and grants with agencies such as the Department of...

The Centers for Disease Control and Prevention awarded a firm fixed price contract valued at $536,153 to The Washington University. The contract is for metabolomic validation of an intestinal microbiome disruption model in support of the agency's broad agency announcement solicitation seeking research in areas including public health, emerging and zoonotic infectious diseases, occupational safety and health, and environmental health. The prime contractor, The Washington University Office of...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $256,309 firm fixed price contract to The Washington University. This contract was awarded under Broad Agency Announcement Number 75D301-20-R-68024, which solicited white papers related to developing strategies for protecting communities from COVID-19 through research projects addressing topics such as virus transmission, sequencing, and controlling spread. The Washington University will determine...

This is a $305,317 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Washington University, a private university in St. Louis, Missouri, to conduct research on "METABOLIC MICROBIOME DISRUPTION". The contract has a completion date of September 25, 2023 and was awarded on September 26, 2022. This award does not have a set-aside designation. The Washington University has a long history of performing research and specialized services for...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $499,983 firm-fixed-price contract to The Washington University in St. Louis, Missouri for COVID-19 related research under the FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1. The contract does not have a small business set-aside designation. The Washington University, a private research university, has extensive experience partnering with federal agencies like the Department of Defense, Department of Veterans...

The Centers for Disease Control and Prevention awarded a firm fixed price definitive contract valued at four hundred eighty-six thousand eight hundred forty-nine dollars ($486,849) to The Washington University for research on the human gut microbiome's disruption and susceptibility to antibiotics. As the prime contractor, The Washington University will conduct the requested research under this contract to the CDC, which focuses on understanding how changes in gut bacteria may impact individuals'...